Atara Biotherapeutics (ATRA) Cost of Revenue (2023 - 2026)
Atara Biotherapeutics' Cost of Revenue was $191,000 in Q2 2026, down 65.5% from $554,000 a year earlier but up 54.0% from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Cost of Revenue (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Atara Biotherapeutics' Cost of Revenue was $534,000 through Jun 30, 2026, down 98.5% year-over-year; for FY2025, it came in at $21.21 million, up 1.0% from FY2024.
- In earlier years, Cost of Revenue was $21.01 million in FY2024 (+136.4%) and $8.89 million in FY2023.
- Quarterly Cost of Revenue has moved between $104,000 (Q4 2025) and $20.44 million (Q1 2025) over five years.
- Compared with a year earlier, Cost of Revenue has declined for five straight quarters, with growth averaging 98.2% over the last eight quarters.
- The best year-over-year quarter for Cost of Revenue over five years was Q1 2025 (growth of 929.7%); the worst was Q1 2026 (a decline of 99.4%).
- Per Business Quant data, ATRA's Cost of Revenue in the three quarters before Q2 2026 was $124,000 (Q1 2026), $104,000 (Q4 2025) and $115,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Atara Biotherapeutics | 142.51 Mn | 132.61 Mn | 439,000.00 | 191,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 191,000.00 |
| Mar 31, 2026 | 124,000.00 |
| Dec 31, 2025 | 104,000.00 |
| Sep 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 554,000.00 |
| Mar 31, 2025 | 20.44 Mn |
| Dec 31, 2024 | 6.80 Mn |
| Sep 30, 2024 | 7.60 Mn |
| Jun 30, 2024 | 4.63 Mn |
| Mar 31, 2024 | 1.99 Mn |
| Dec 31, 2023 | 3.16 Mn |
| Sep 30, 2023 | 2.62 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 216,000.00 |
API Access
Atara Biotherapeutics Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();